Current and future use of intravenous thrombolysis for acute ischemic stroke

Current Atherosclerosis Reports

Volumn 12, Issue 5, 2010, Pages 316-321

  Elijovich, Lucas ^a   Chong, Ji Y ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

Acute ischemic stroke; Endovascular treatment; Thrombolysis; TPA

Indexed keywords

EPTIFIBATIDE; PLACEBO; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL PRACTICE; CLINICAL TRIAL; DIFFUSION WEIGHTED IMAGING; DISABILITY; DOPPLER ECHOGRAPHY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG USE; HUMAN; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; RECANALIZATION; REVIEW; SYMPTOM; TREATMENT RESPONSE;

BRAIN INFARCTION; FIBRINOLYTIC AGENTS; HUMANS; INJECTIONS, INTRAVENOUS; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 77956257659     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-010-0121-8     Document Type: Review

References (24)

1. Tissue plasminogen activator for acute ischemic stroke 1995 The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group N Engl J Med 333 1581 1587 10.1056/NEJM199512143332401
2. HP Adams G del Zoppo MJ Alberts, et al. 2007 American Heart Association; American Stroke Association Stroke Council; Clinical Cardiology Council; Cardiovascular Radiology and Intervention Council; Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: Guidelines for the early management of adults with ischemic stroke Stroke 38 1655 1711 10.1161/STROKEAHA.107.181486 17431204 This is a comprehensive review of AHA-recommended treatment for patients with acute ischemic stroke
3. EE Smith AR Abdullah I Petkovska, et al. 2005 Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischemic stroke Stroke 36 2497 2499 10.1161/01.STR.0000185798.78817.f3 1:CAS:528:DC%2BD2MXhtFaksb7F 16210552
4. N Wahlgren N Ahmed A Davalos, et al. 2007 Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study Lancet 369 275 282 10.1016/S0140-6736(07)60149-4 1:CAS:528:DC%2BD2sXpvV2gtw%3D%3D 17258667 This study provides safety data from a registry of patients treated in the community with IV tPA
5. S Arora JP Broderick M Frankel, et al. 2005 Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry Stroke 36 1232 1240 10.1161/01.STR.0000165902.18021.5b 15890989
6. W Hacke G Donnan C Fieschi, et al. 2004 Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials Lancet 363 768 774 10.1016/S0140-6736(04)15692-4 15016487
7. W Hacke M Kast E Bluhmki, et al. 2008 Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke N Engl J Med 359 1317 1329 10.1056/NEJMoa0804656 1:CAS:528:DC%2BD1cXhtFGqu77E 18815396 This randomized clinical trial of IV tPA in patients 3 to 4.5 hours after acute ischemic stroke onset showed safety and efficacy of treatment
8. JL Saver J Gornbein J Grotta, et al. 2009 Number needed to treat to benefit and to harm for intravenous tissue plasminogen activator therapy in the 3 to 4.5 h window : Joint outcome table analysis of the ECASS 3 trial Stroke 40 2433 2437 10.1161/STROKEAHA.108.543561 1:CAS:528:DC%2BD1MXnsFyju74%3D 19498197
9. G del Zoppo JL Saver EC Jauch HP Adams 2009 Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a Science Advisory from the American Heart Association/American Stroke Association Stroke 40 2945 2948 10.1161/STROKEAHA.109.192535 19478221 The AHA recommends expanding the IV tPA window based on recent studies but includes new exclusion criteria for the expanded window
10. Albers G for the DEFUSE Investigators: Magnetic resonance imaging profiles predict clinical response to early reperfusion: the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke (DEFUSE) Study. Ann Neurol 2006, 60:508-517.
11. S Davis for the EPITHET Investigators 2008 Effect of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial Lancet Neurol 7 299 309 10.1016/S1474-4422(08)70044-9 18296121
12. A Flint GR Duckwiler RF Budzik, et al. 2007 MERCI and Multi MERCI Writing Committee: Mechanical thrombectomy of intracranial internal carotid occlusion: pooled results of the MERCI and Multi MERCI Part I trials. Multi MERCI Writing Committee Stroke 38 1274 10.1161/01.STR.0000260187.33864.a7 17332445
13. A Furlan R Higashida L Wechsler, et al. 1999 Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial JAMA 282 2003 2011 10.1001/jama.282.21.2003 1:CAS:528:DC%2BD3cXhtFek 10591382
14. AV Alexandrov for the CLOTBUST Investigators 2004 Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke N Engl J Med 351 2170 2178 10.1056/NEJMoa041175 1:CAS:528:DC%2BD2cXhtVSqtLzO 15548777
15. CA Molina AD Barreto G Tsivgoulis, et al. 2009 Transcranial ultrasound in clinical sonothrombolysis (TUCSON) trial Ann Neurol 66 28 38 10.1002/ana.21723 1:CAS:528:DC%2BD1MXhtFWju7bL 19670432
16. A Ogawa for the MELT Japan Study Group 2007 The local randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: Middle Cerebral Artery Embolism Fibrinolytic Intervention Trial (MELT) Japan Stroke 38 2633 2639 10.1161/STROKEAHA.107.488551 1:CAS:528: DC%2BD2sXhtVKhtrzJ 17702958
17. The Penumbra Pivotal Stroke Trial Investigators 2009 Safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease: the Penumbra Pivotal Stroke trial Stroke 40 2761 2768 10.1161/STROKEAHA.108.544957
18. WS Smith for the Multi MERCI Investigators 2006 Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the Multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, Part 1 Am J Neuroradiol 27 1177 1182 1:STN:280: DC%2BD28zmtVajtA%3D%3D 16775259
19. The IMS II Trial Investigators 2007 The Interventional Management of Stroke (IMS) II study Stroke 38 2127 2135 10.1161/STROKEAHA.107.483131
20. AM Pancioli J Broderick T Brott, et al. 2008 The combined approach to lysis utilizing eptifibatide and rtPA in acute ischemic stroke: the CLEAR stroke trial Stroke 39 3268 3276 10.1161/STROKEAHA.108.517656 1:CAS:528: DC%2BD1cXhtlylt7nJ 18772447
21. BC Meyer R Raman T Hemmen, et al. 2008 Efficacy of site-independent telemedicine in the STRokE DOC trial: a randomised, blinded, prospective study Lancet Neurol 7 787 795 10.1016/S1474-4422(08)70171-6 1:CAS:528: DC%2BD1cXhtFWmsLrN 18676180
22. HJ Audebert C Kukla SC von Claranau, et al. 2005 Telemedicine for safe and extended use of thrombolysis in stroke: the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria Stroke 36 287 291 10.1161/01.STR.0000153015.57892.66 1:CAS:528:DC%2BD2MXmtVWhtw%3D%3D 15625294
23. MA Pervez G Silva S Masrur, et al. 2010 Remote supervision of IV tPA for acute ischemic stroke by telemedicine or telephone before transfer to a regional stroke center is feasible and safe Stroke 41 e18 e24 10.1161/STROKEAHA.109. 560169 19910552
24. LH Schwamm H Audebert P Amarenco, et al. 2009 Recommendations for the implementation of telemedicine within stroke systems of care: a policy statement from the American Heart Association Stroke 40 2635 2660 10.1161/STROKEAHA.109. 192361 19423851